big pharma has always been playing the propaganda corner, nicorette own 37% of the NRT market share, they stand to lose alot (37% is roughly $400million per year) what i dont understand is with all their money and power why they are so against this product. With all their power they could easily corner the market in a week securing patents on all common products and mass producing and marketing ecigs alongside the other NRT products.
To a big P company $400m is pocket change.
Nicorette is owned by Johnson & Johnson who had revenues in 2012 of $65
billion. Which puts it's total income from Nicorette at
0.6% of total revenue.
in contrast varenicline (Chantix/Champix) has similar sales figues (2009 some $150million) that's owned by Pfizer. Pfizer made a touch under $59
billion in 2012 and to date varenicline has cost them a LOT in settled lawsuits. There are a lot of reports of deaths associated with that drug, which was launched around the same time as e-cigs emerged onto the market. To date there is not one single reported case of death by overdose/poisoning from normal use of e-cigarettes. There has been 1 tragic case of poisoning by accidental overdose and quite a few reported fires caused by battery issues.
the money big P stands to lose is in the treatment of smoking related disease. In the longer term of course people are still going to get sick and die from disease, so ultimately the big pharmaceutical companies aren't really going to lose any money, but treating smoking related disease is the 'low hanging fruit' kind of easy money, it costs in the US about ~$125k per case to treat an average cancer and lung cancer is by far the most prevalent (most of that is caused by smoking tobacco) [
linky]
Also a 12mg limit would be as good as fatal. the most popular strength we sell is 18mg/ml we have some customers that prefer 36mg/ml and a lot that prefer 24mg/ml - it's important to not too that when people first switch to e-cigs usually tehy are using a cig-alike or an fixed voltage ego with a crap (too high ohm) clearomiser. Because of the limitations of the nicotine delivery inherent in those kinds of setups the new vaper often needs to use a higher strength liquid to compensate, otherwise ecigs don't work for them and they end up smoking again. Whoever wrote that press release knows that. the less effective at attracting new smokers vaping is the more 'easy money' the Pharma companies lock into their profits (and the more smokers die from their smoking related diseases)
